Goldman Sachs Maintains Sell on Solventum, Raises Price Target to $54
Solventum Corporation Common Stock +0.71%
Solventum Corporation Common Stock SOLV | 67.74 | +0.71% |
Goldman Sachs analyst David Roman maintains Solventum (NYSE:
SOLV) with a Sell and raises the price target from $48 to $54.